Skip to main content
Premium Trial:

Request an Annual Quote

Biocept, UCSD to Study Liquid Biopsy to Predict Cancer Recurrence, Therapy Response

NEW YORK (GenomeWeb) – Biocept said today that it is collaborating with the UCSD Moores Cancer Center in two new clinical studies designed to evaluate the ability of Biocept's Target Selector liquid biopsy assays to predict cancer recurrence and treatment response.

The studies, focused on individuals with breast, lung, and colon cancer, will use Biocept's technology to search for circulating tumor cells and circulating tumor DNA, comparing results with findings from CT or PET scans. The first study will evaluate the ability of the company's tests to predict disease recurrence in patients with Stage II or III cancer who are at high risk for recurrence.

The second will look at the feasibility of using the firm's liquid biopsy technology to predict response to therapy in patients with metastatic solid tumors.  

Razelle Kurzrock, director of the Center for Personalized Cancer Therapy and Clinical Trials Office at the Moores Cancer Center, said in a statement that the risk for post-surgery disease recurrence remains very high, despite the development of adjuvant treatment strategies. Moreover, because of the limitations and cost of CT imaging, there is a great need for alternative methods to identify reemerging cancers more quickly and effectively.

Biocept had already collaborated with UCSD in several other investigations of its technology, including the detection of tumor mutations and PD-L1 expression in the blood of advanced lung cancer patients.

"We are enthusiastic about working with UC San Diego Health on these clinical studies to further demonstrate the clinical utility of our … platform," Biocept President and CEO Michael Nall added. "We believe that clinical results from our technologies can provide physicians with important information to better predict a patient's response to therapy and monitor their disease progress and recurrence, which can lead to better patient outcomes."

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.